Literature DB >> 32460817

Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer.

Chen Hu1, Yu Bai2, Jun Li1, Guoyin Zhang1, Libo Yang1, Chengwei Bi1, Bin Zhao1, Yong Yang1, Ruiqian Li1, Hongyi Wu1, Qilin Wang1, Yang Qin1.   

Abstract

BACKGROUND: Penile squamous cell carcinoma (PSCC) represents an important public health problem for developing countries. The major prognostic factors in PSCC are pathological subtype, perineural invasion, lymphovascular invasion, depth of invasion and grade, which are hard to obtain precisely before the operation. Besides, micro-metastases will be detected in about 30% of intermediate-risk patients with clinically non-palpable inguinal lymph nodes after inguinal lymph node dissection (ILND). It means approximately 70% of patients are unable to benefit from ILND who might suffered from the complications of surgery. We hope some biomarkers could be found which are able to predict the outcome before surgery and reflect the inguinal lymph nodes metastasis.
METHODS: A total of 349 consecutive patients of penile cancer in Yunnan cancer hospital in China between October 2002 and December2017. Two hundred twenty-five was succeed to follow-up. The association between NLR, LMR, PLR, LDH and Overall survival (OS), progression free survival (PFS), inguinal lymph node (N stage) was analyzed with K-M analysis, univariable, multivariable logistic regression and Kendall's tau-b correlation coefficient.
RESULTS: Multivariable analysis reveal that only PLR was significant independent factor which is associated with inferior OS and PFS; Age and LDH was associated with inferior OS; Lymph node and metastatic status remained significant for OS and PFS as NCCN and EAU Guidelines indicated; the tumor type, initial treatment and NLR LMR were not significant in predicting both OS and PFS. NLR, LMR and PLR were corresponded to N stage, while LDH was not associated with the N stage based on logistic regression model analysis. NLR, LMR and PLR were found weakly related to N stage through an application of Kendall's tau-b correlation coefficient.
CONCLUSIONS: PLR was significant independent factors for OS and PFS, Age and LDH was significant independent factors for OS. NLR, LMR, PLR was corresponded to N stage.

Entities:  

Keywords:  LDH; LMR; NLR; PLR; Penile cancer

Mesh:

Substances:

Year:  2020        PMID: 32460817      PMCID: PMC7251912          DOI: 10.1186/s12894-020-00628-z

Source DB:  PubMed          Journal:  BMC Urol        ISSN: 1471-2490            Impact factor:   2.264


Background

Penile squamous cell carcinoma has a low incidence among all cancers, according to the report there are 26,000 new cases occurring worldwide annually [1]. However, in developing countries such as Africa, Asia, South America, etc. penile cancer is still a difficult problem, where its incidence varies from 3 to 8.3 cases per 100,000 [2], especially in southwestern of China. The management of the regional lymph nodes is extremely important for long-term survival of the patient according to the National Comprehensive Cancer Network (NCCN) and the European Association of Urology (EAU) clinical practice guidelines. Both guidelines subdivide penile cancer into three groups of low risk, intermediate risk and high risk. Low-risk patients with non-palpable inguinal lymph node (cN0) can be managed by surveillance or dynamic sentinel node biopsy (DSNB), however, due to earlier Inguinal Lymph Node Dissection (ILND) surgery has a better prognosis than ILND after local lymph node recurrence, the indications for ILND recommended by the guidelines are do the operation as long as the inguinal lymph node are palpable, whether it is low-risk, moderate or high risk [3]. However intermediate-risk patients with clinically non-palpable inguinal lymph nodes, only about 30% of them are able to detect micro-metastases after ILND. That means the rest of patients approximately 70% have no benefit from ILND and suffered from the complications of surgery. So it is crucial to selected the patients who are really benefits from ILND before surgery. Because prognosis of PSCC is highly correlated with lymph nodes stage, plenty of articles have select patients through the prognostic role of biomarkers. The major prognostic factors in PSCC are perineural invasion, pathological subtype, depth of invasion, grade and lymphovascular invasion [4, 5]. These factors are hard to precisely obtain before the operation. Besides some articles used biomarkers such as p53 and squamous cell carcinoma antigen to predict inguinal lymph node positive rate and prognosis of penile cancer, but they were not applied to clinical practice [6, 7]. So we hope to find some markers that is associated with inguinal lymph nodes metastatic or can predict the outcomes. As we known that systemic inflammatory factors play an significant role in cancer progression [8, 9]. The tumor micro-environment regulated by inflammatory cells is clearly related to cancer progression [8]. Systemic inflammatory factors are obviously reflected by changes of peripheral leukocyte, lymphocytes,neutrophils, monocytes and platelets. These factors above mentioned can reflect the tumor micro environment indirectly [8], so we collected the data of peripheral blood parameters including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR) which have been reported to be independent prognostic factors in various of cancers [8, 10–14]. Besides, high lactate dehydrogenase (LDH) has also shown that associated with poor OS in urologic cancer [15]. Recently it has been reported that cancer patients with high NLR is associated with worse OS [16] and worse RFS and CSS [17, 18]. However, there has been no study evaluating the PLR associated with outcomes of penile cancer. In this retrospective study, we investigated the role of NLR, LMR, PLR and LDH before surgery to predicting whether micro-metastases of inguinal lymph node exist and assessed the prognostic value in penile cancer.

Methods

We reviewed our electronic medical records system to identify men treated for penile SCC at Yunnan cancer hospital in China between October 2002 and December 2017. Experimental procedures were approved by the Human Ethics Committee of Yunnan Cancer Hospital.A total of 349 consecutive patients treated with ILND in PSCC, 225 was succeed to follow-up, Epidemiological and clinical data, including age, preoperative full blood count results NLR, LMR, PLR LDH and TNM clinical staging, tumor pathology, treatment history and oncological outcome (OS, PFS). Survival analysis was performed by the Kaplan–Meier method for univariable analysis and Cox regression method for multivariable analysis. The NLR was calculated by neutrophil-to-lymphocyte ratio, LMR was lymphocyte-to-monocyte ratio and PLR was platelet-to lymphocyte ratio which were obtained through peripheral complete blood count and blood biochemistry before the surgery. We calculate the cut-off point of the Ages, NLR, LMR, PLR and LDH according to the area under curve (AUC) given consideration to sensitivity and specificity levels. The primary end point were overall survival (OS) and progression free survival (PFS) which defined as the time from the dates of pathological diagnosis to death and tumor progression. Univariable analysis (K-M analysis) was performed to compare the higher and lower groups of NLR, LMR, PLR and LDH. Multivariable analysis (COX logistic regression) were used to verify the individual factors respectively. P values less than 0.05 were considered statistical significance. We also analyse the relation between the NLR, LMR, PLR, LDH and N stage through the logistic regression, meantime we use method of Kendall’s tau-b correlation coefficient to determine the correlation.

Results

NLR, LMR, PLR, LDH vs OS/PFS

A total of 225 patients had collected peripheral complete blood count and blood biochemistry before surgery. The mean (±SD) ages were 50.6 ± 13.4. The detailed data of patients are summarized in Table 1. We performed AUC curve to determine the Age, NLR, LMR, PLR and LDH cut-off value which were 53,2.94,4.74,133.5 and 188.5 respectively. The median interquartile range follow-up was 30 (16.0–63.5) months. Among the 225 patients, 171 was survival which the median interquartile range follow-up was 34 (18.0–84.0) months; 150 was disease free which the median interquartile range follow-up was 33 (18.0–85.25) months; 29 was alive with disease progression,8 was dead of other causes.
Table 1

Patients’ characteristics

VariableNLRLMRPLRLDH
All n=225NLR≤2.94NLR>2.94pLMR≤4.74LMR>4.74pPLR≤133.5PLR>133.5pLDH≤188.5LDH>188.5p
Age, y0.2960.1690.5660.184
 <531401033755851053511525
 ≥53855431454055306520
Tumor type0.0260.0910.1310.943
 benign443591727386359
 well966927395762347917
 moderate744925353952225915
 poor844716262
 others303212121
Anatomic stage0.0020.0630.0050.076
 0443391725366339
 I675116234448195710
 II3928111821318336
 III624121313139225012
 IV154111146987
N stage0.0010.0240.0090.053
 01481123658901153312325
 128151318101513244
 236261015212412279
 31349946776
M0.0080.0510.1460.545
 022215765971251596317943
 1303301221
Initial treatment0.0040.0940.8630.052
 surveillance231013149167158
 surgery22514755851161445916636
Recurrence0.010.6350.0040.235
 no1501133765851163412426
 yes754431354044315718
Vital status0.0000.00100.003
 Alive17113140651061343714526
 Dead542628351926283618
Patients’ characteristics On Kaplan-Meier analysis, NLR > 2.94 was associated with inferior OS (log-rank p = 0.001), and inferior PFS (log-rank p = 0.004) in Figs. 1 and 2; LMR > 4.74 was associated with inferior OS (log-rank p = 0.001), but not associated with PFS (log-rank p = 0.547) in Figs. 3 and 4; PLR > 133.5 was associated with inferior OS (log-rank p < 0.001) and inferior PFS (log-rank p = 0.001) in Figs. 5 and 6. LDH < 188.5 was associated with inferior OS (log-rank p = 0.004), but not associated with PFS (log-rank p = 0.155) in Figs. 7 and 8.
Fig. 1

KaplanMeier curve of NLR for overall survival (OS)

Fig. 2

KaplanMeier curve of NLR for progression free survival (PFS)

Fig. 3

KaplanMeier curve of LMR for overall survival (OS) and 4

Fig. 4

KaplanMeier curve of LMR for progression free survival (PFS)

Fig. 5

KaplanMeier curve of PLR for overall survival (OS)

Fig. 6

KaplanMeier curve of PLR for progression free survival (PFS)

Fig. 7

KaplanMeier curve of LDH for overall survival (OS)

Fig. 8

KaplanMeier curve of LDH for progression free survival (PFS)

KaplanMeier curve of NLR for overall survival (OS) KaplanMeier curve of NLR for progression free survival (PFS) KaplanMeier curve of LMR for overall survival (OS) and 4 KaplanMeier curve of LMR for progression free survival (PFS) KaplanMeier curve of PLR for overall survival (OS) KaplanMeier curve of PLR for progression free survival (PFS) KaplanMeier curve of LDH for overall survival (OS) KaplanMeier curve of LDH for progression free survival (PFS) In univariable analyses, NLR > 2.94 was associated with inferior OS (HR = 2.967; 95% CI: 1.739–5.064, p < 0.001) and inferior PFS (HR = 1.944; 95% CI: 1.226–3.081,p = 0.005); LMR > 4.74 was associated with inferior OS (HR = 0.394; 95% CI: 0.225–0.689, p = 0.001) and not associated with inferior PFS (HR = 0.871; 95% CI: 0.553–1.372,p = 0.551); PLR > 133.5 was associated with inferior OS (HR = 3.439; 95% CI: 2.011–5.881, p < 0.001) and inferior PFS (HR = 2.194; 95% CI: 1.384–3.478,p = 0.001); LDH > 188.5 was associated with inferior OS (HR = 2.252; 95% CI: 1.267–4.002, p = 0.006) and not associated with inferior PFS (HR = 1.462; 95% CI: 0.859–2.487,p = 0.162). We performed a multivariate analysis which reveal NLR was not significant independent factors for OS(p = 0.516) and PFS(p = 0.594); LMR was not associated with OS(p = 0.97) and PFS; PLR was significant independent factors for both OS(p = 0.001) and PFS(p = 0.02); LDH was significant independent factors for OS(P = 0.035) but not for PFS. At multivariate analysis, lymph node status (P = 0.03) and metastasis status remained significant for OS and PFS as NCCN or EAU Guidelines indicated; However, ages, the tumor type and initial treatment was not significant for OS and PFS in multivariable analyses (Table 2).
Table 2

Cox regression model for OS and PFS

VariablesOSPFS
UnivariableMultivariableUnivariableMultivariable
HR95%CIpHR95%CIpHR95%CIpHR95%CIp
Ages
 <53reference1.077-3.1740.026reference1.055-3.9830.035reference0.785-1.9740.352
 ≥531.8491.9611.245
Tumor type
 benign tumorreference0.002reference0.205reference0.006reference0.135
 Well0.970.021-0.4480.3050.054-1.7150.0460.039-0.9700.4050.075-2.186
 moderate0.2110.060-0.7370.220.052-0.9380.3320.116-2.0700.510.111-2.336
 poor0.4470.130-1.5410.4190.106-1.6550.8680.211-3.7160.8950.201-3.982
 others0.5940.130-2.7190.2650.051-1.3780.6460.109-3.9440.3010.043-2.112
Inguinal lymph node
 negigitvereference5.243-20.9180.000reference3.224-15.7840.000reference3.096-8.0800.000reference2.198-6.2500.000
 positive10.4727.1335.0023.706
Metastasis
 0reference6.637-85.9270.000reference2.223-40.2380.002reference2.484-26.5050.001reference1.184-18.0720.028
 123.8819.4588.1144.626
Initial treatment
 surveillancereference0.222-0.9370.033reference0.18-1.0060.052reference0.345-1.3070.241
 surgery0.4560.4250.671
NLR
 low NLRreference1.739-5.0640.000reference0.605-2.7180.516reference1.226-3.0810.005reference0.679-1.9660.594
 high NLR2.9671.2831.9441.115
LMR
 low LMRreference0.025-0.6890.001reference0.448-2.1640.97reference0.553-1.3720.871
 high LMR0.3940.9850.551
PLR
 low PLRreference2.011-5.8810.000reference1.644-6.1710.001reference1.384-3.4780.001reference1.104-3.2420.02
 high PLR3.4393.1862.1941.892
LDH
 low LDHreference1.267-4.0020.006reference1.051-3.8080.035reference0.859-2.4870.162
 high LDH2.25221.462
Cox regression model for OS and PFS

NLR LMR PLR LDH vs inguinal lymph node-negative/positive

In logistic regression analyses, NLR (HR = 2.212; 95% CI: 1.228–3.985,p = 0.008), LMR (HR = 0.537; 95% CI: 0.308–0.937,p = 0.029), PLR (HR = 2.478; 95% CI:1.365–4.497,p = 0.003) was significant corresponded to N stage which divided into the Node-negative group and Node-positive groups, however the LDH (p = 0.165) was not associated with the N stage. Meantime we also use Kendall’s tau-b method to evaluated the correlations, NLR (Kendall’s tau-b = 0.131, P = 0.017) LMR (Kendall’s tau-b = − 0.109, P = 0.046) PLR (Kendall’s tau-b = 0.161, P = 0.003) were weakly correlated to the N stage. In other words, higher NLR, PLR and lower LMR was more likely to detected pathologically positive inguinal lymph node after ILND. The biomarkers of NLR LMR and PLR could predict the pathological outcomes of ILND.

Discussion

In recent years, the role of inflammatory factors in cancer development and progression has received more attention. The tumor micro-environment may be associated with systemic inflammation. Several types of cancer have been adopt inflammatory factors in prognostic scores for predict the outcome [19] and IMDC scores of advanced renal cell carcinoma also added those factors. Recently, an elevated ratio of peripheral neutrophils-to-lymphocytes (NLR) has been recognized as a poor prognostic indicator in penile cancer, Patients with a high NLR had significantly worse CSS [17, 18] and OS [16];Patients with a low LMR had significantly worse RFS and CSS than those with a high LMR [18]. However, there is no date about the PLR and LDH in penile cancer, this paper aims to collect data from China and conduct comparative analysis of NLR, LMR, PLR and LDH, these bio-markers are critical in guiding clinical management decisions and follow-up strategies. The incidence of penile cancer itself is very low, so it is difficult to analyze with a large sample size. The incidence of penile cancer is relatively high in China, especially in Yunnan Province, so the sample size of this paper is relatively large. In addition, it is difficult to judge whether there is lymph node metastasis before ILND, therefore, we also hope to assist in judgment whether there is lymph node metastasis from these indicators, so that we can choose the different surgical approach. We acknowledge the several limitations to this study including inherent biases associated with its retrospective design, insufficient time to follow-up and population heterogeneity. Besides, more than 20% of the patients were lost to follow-up which may affect the statistical results. We originally wanted to analyze C-reactive protein (CRP) at the same time. Since the early patients failed to perform CRP testing uniformly, the indicator failed to enter the analysis.

Conclusion

PLR was significant independent factors for OS and PFS, Ages and LDH was significant independent factors for OS. NLR, LMR, PLR was corresponded to N stage.
  18 in total

1.  Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer.

Authors:  Hyuk-Chan Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Ji Hyun Lee; Hong-Jo Choi; Ki-Jae Park; Mee Sook Roh; Seung-Geun Kim; Hyo-Jin Kim; Jong Hoon Lee
Journal:  Biomarkers       Date:  2012-03-17       Impact factor: 2.658

2.  The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.

Authors:  Yao Zhu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

3.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Authors:  Robert S Sandler; Susan Halabi; John A Baron; Susan Budinger; Electra Paskett; Roger Keresztes; Nicholas Petrelli; J Marc Pipas; Daniel D Karp; Charles L Loprinzi; Gideon Steinbach; Richard Schilsky
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

4.  The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.

Authors:  Yao Zhu; Xiao Y Zhou; Xu D Yao; Bo Dai; Ding W Ye
Journal:  BJU Int       Date:  2007-04-13       Impact factor: 5.588

5.  Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer.

Authors:  Viren Asher; Joanne Lee; Anni Innamaa; Anish Bali
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

Review 6.  Prognostic Role of Lactate Dehydrogenase Expression in Urologic Cancers: A Systematic Review and Meta-Analysis.

Authors:  Yong Zhang; Ting Xu; Yi Wang; Hong Zhang; Yang Zhao; Xuecheng Yang; Yanwei Cao; Wu Yang; Haitao Niu
Journal:  Oncol Res Treat       Date:  2016-09-12       Impact factor: 2.825

7.  Worldwide burden of cancer attributable to HPV by site, country and HPV type.

Authors:  Catherine de Martel; Martyn Plummer; Jerome Vignat; Silvia Franceschi
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

8.  Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.

Authors:  Mounsif Azizi; Charles C Peyton; David C Boulware; Juan Chipollini; Timothy Juwono; Julio M Pow-Sang; Philippe E Spiess
Journal:  Eur Urol Focus       Date:  2018-06-22

9.  Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer.

Authors:  Jun Kasuga; Takashi Kawahara; Daiji Takamoto; Sachi Fukui; Takashi Tokita; Tomoyuki Tadenuma; Masaki Narahara; Syusei Fusayasu; Hideyuki Terao; Koji Izumi; Hiroki Ito; Yusuke Hattori; Jun-Ichi Teranishi; Takeshi Sasaki; Kazuhide Makiyama; Yasuhide Miyoshi; Masahiro Yao; Yasushi Yumura; Hiroshi Miyamoto; Hiroji Uemura
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

10.  Management of penile cancer in a Singapore tertiary hospital.

Authors:  Teck Wei Tan; Sing Joo Chia; Kian Tai Chong
Journal:  Arab J Urol       Date:  2017-03-30
View more
  8 in total

1.  High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine.

Authors:  Liru Li; Lin Ai; Lin Jia; Lei Zhang; Boya Lei; Qingyuan Zhang
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

2.  Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study.

Authors:  Yuhua Feng; Na Zhang; Sisi Wang; Wen Zou; Yan He; Jin-An Ma; Ping Liu; Xianling Liu; Chunhong Hu; Tao Hou
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

3.  Copy Number Analysis Reveal Genetic Risks of Penile Cancer.

Authors:  Yongbo Yu; Chengwen Gao; Yuanbin Chen; Meilan Wang; Jianfeng Zhang; Xiaocheng Ma; Shuaihong Liu; Hang Yuan; Zhiqiang Li; Haitao Niu
Journal:  Front Oncol       Date:  2020-12-14       Impact factor: 6.244

4.  Controlling Nutritional Status (CONUT) Score as a New Indicator of Prognosis in Patients With Hilar Cholangiocarcinoma Is Superior to NLR and PNI: A Single-Center Retrospective Study.

Authors:  Ankang Wang; Zhenxing He; Peng Cong; Yueyu Qu; Tao Hu; Yu Cai; Bo Sun; Hao Chen; Wenguang Fu; Yong Peng
Journal:  Front Oncol       Date:  2021-01-11       Impact factor: 6.244

5.  A Prognostic Model Based on Clinicopathological Features and Inflammation- and Nutrition-Related Indicators Predicts Overall Survival in Surgical Patients With Tongue Squamous Cell Carcinoma.

Authors:  Lai-Feng Wei; Xu-Chun Huang; Yi-Wei Lin; Yun Luo; Tian-Yan Ding; Can-Tong Liu; Ling-Yu Chu; Yi-Wei Xu; Yu-Hui Peng; Hai-Peng Guo
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

6.  Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy.

Authors:  Zihan Zhang; Qian Lin; Yi Chen; Chenlin Su; Wuye Lin; Daoyu Wei; Litu Zhang; Haizhou Liu
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

Review 7.  Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in penile cancer: A systematic review and meta-analysis.

Authors:  Haviv Muris Saputra; Furqan Hidayatullah; Yudhistira Pradnyan Kloping; Johan Renaldo; Eric Chung; Lukman Hakim
Journal:  Ann Med Surg (Lond)       Date:  2022-08-05

8.  Development and Validation of a Nomogram for the Prediction of Inguinal Lymph Node Metastasis Extranodal Extension in Penile Cancer.

Authors:  Chong Wu; Zaishang Li; Shengjie Guo; Fangjian Zhou; Hui Han
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.